JO
AURA icon

John Overdeck’s Aura Biosciences AURA Stock Holding History

John Overdeck’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,512
Closed -$226K – 3198
2024
Q4 		$226K Sell
27,512
-6,911
-20% -$65K ﹤0.01% 2837
2024
Q3 		$307K Sell
34,423
-51,860
-60% -$445K ﹤0.01% 2659
2024
Q2 		$652K Sell
86,283
-27,606
-24% -$202K ﹤0.01% 2229
2024
Q1 		$894K Buy
113,889
+71,502
+169% +$593K ﹤0.01% 2019
2023
Q4 		$376K Buy
+42,387
New +$359K ﹤0.01% 2597

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

John Overdeck's AURA Position: Q1 2025 in Review

John Overdeck sold out of Aura Biosciences (AURA) in Q1 2025, closing a stake of 27,512 shares — an estimated $226K sold.

John Overdeck first reported a position in AURA in Q4 2023 and held it in 5 quarters. The position peaked at $894K in Q1 2024. 94 funds tracked by Wall St. Rank hold AURA as of Q1 2025.

  • John Overdeck reported no remaining Aura Biosciences position as of Q1 2025 after selling out during the quarter.
  • John Overdeck sold 27,512 Aura Biosciences shares in Q1 2025, an estimated $226K.
  • John Overdeck first reported a position in Aura Biosciences in Q4 2023 and held it in 5 quarters.
  • John Overdeck's Aura Biosciences position peaked at $894K in Q1 2024.
  • 94 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.